Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term estrogen. Found 17 abstracts

Gong Y, Huo L, Liu P, Sneige N, Sun X, Ueno NT, Lucci A, Buchholz TA, Valero V, Cristofanilli M. Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome. Cancer. 2011 Dec;117(24):5476-84.   PMCID: not NIH funded
Betancourt AM, Eltoum IA, Desmond RA, Russo J, Lamartiniere CA. In Utero Exposure to Bisphenol A Shifts the Window of Susceptibility for Mammary Carcinogenesis in the Rat. Environmental Health Perspectives. 2010 Nov;118(11):1614-9.   PMCID: PMCID: PMC2974702
Gaudet MM, Falk RT, Gierach GL, Lacey JV, Graubard BI, Dorgan JF, Brinton LA. Do adipokines underlie the association between known risk factors and breast cancer among a cohort of United States women?. Cancer Epidemiology. 2010 Oct;34(5):580-6.   PMCID: PMCID: PMC2949443 [Available on 2011/10/1]
Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, Bevers TB, Fehrenbacher L, Pajon ER, Wade JL, Robidoux A, Margolese RG, James J, Runowicz CD, Ganz PA, Reis SE, McCaskill-Stevens W, Ford LG, Jordan VC, Wolmark N, Natl Surgical Adjuvant Breast B. Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer. Cancer Prevention Research. 2010 Jun;3(6):696-706.   PMCID: PMC2935331
Santen R, Cavalieri E, Rogan E, Russo J, Guttenplan J, Ingle J, Yue W. Estrogen Mediation of Breast Tumor Formation Involves Estrogen Receptor-Dependent, as Well as Independent, Genotoxic Effects. Steroid Enzymes and Cancer. 2009 Jan;1155:132-40.
Fernandez SV, Russo IH, Russo J. Estradiol and its metabolites 4-hydroxyestradiol and 2-hydroxyestradiol induce mutations in human breast epithelial cells. International journal of cancer. 2006 Apr;118(8):1862-8.
Shatalova EG, Loginov VI, Bragar EA, Kazubskaja TP, Sudomoina MA, Blanchard RL, Favorova OO. Association of polymorphisms in SULTIAI and UGTIAI genes with breast cancer risk and phenotypes in Russian women. MOLECULAR BIOLOGY. 2006 Mar;40(2):263-70.
Spurdle AB, Antoniou AC, Kelemen L, Holland H, Peock S, Cook MR, Smith PL, Greene MH, Simard J, Plourde M, Southey MC, Godwin AK, Beck J, Miron A, Daly MB, Santella RM, Hopper JL, John EM, Andrulis IL, Durocher F, Struewing JP, Easton DF, Chenevix-Trench G. The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology Biomarkers & Prevention. 2006 Jan;15(1):76-9.
Wakelee HA, Wang W, Schiller JH, Langer CJ, Sandler AB, Belani CP, Johnson DH, Eastern Cooperative Oncology Grp. Survival differences by sex for patients with advanced non-small cell lung cancer on Eastern Cooperative Oncology Group trial 1594. JOURNAL OF THORACIC ONCOLOGY. 2006 Jun;1(5):441-6.
Fernandez SV, Russo IH, Lareef M, Balsara B, Russo J. Comparative genomic hybridization of human breast epithelial cells transformed by estrogen and its metabolites. International Journal of Oncology. 2005 Mar;26(3):691-5.
Lareef MH, Garber J, Russo PA, Russo IH, Heulings R, Russo J. The estrogen antagonist ICI-182-780 does not inhibit the transformation phenotypes induced by 17-beta-estradiol and 4-OH estradiol in human breast epithelial cells. International Journal of Oncology. 2005 Feb;26(2):423-9.
Park WC, Liu H, Schafer JM, Jordan VC. Deregulation of estrogen induced telomerase activity in tamoxifen-resistant breast cancer cells. International Journal of Oncology. 2005 Nov;27(5):1459-66.
Anderson PR, Hanlon AL, Movsas B, Hanks GE. Prostate cancer patient subsets showing improved bNED control with adjuvant androgen deprivation. International Journal of Radiation Oncology Biology Physics. 1997 Dec;39(5):1025-30.
Calaf G, Tahin Q, Alvarado ME, Estrada S, Cox T, Russo J. Hormone Receptors and Cathepsin-D Levels in Human Breast Epithelial-Cells Transformed by Chemical Carcinogens and C-Ha- Ras Transfection. Breast Cancer Research and Treatment. 1994 Jan;29(2):169-77.
Chien CH, Wang FF, Hamilton TC. Transcriptional Activation of C-Myc Protooncogene by Estrogen in Human Ovarian-Cancer Cells. Molecular and Cellular Endocrinology. 1994 Feb;99(1):11-9.
Godwin AK, Testa JR, Hamilton TC. The Biology of Ovarian-Cancer Development. Cancer. 1993 Jan 15;71(2):530-6.
Seal SN, Davis DL, Burch JB. Mutational studies reveal a complex set of positive and negative control elements within the chicken vitellogenin II promoter. Molecular and Cellular Biology. 1991 Jan;11(5):2704-17.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term estrogen

estrogen expression breast cancer survival gene carcinoma hormone-replacement therapy therapy 4-OH-estradiol prostate-cancer receptor susceptibility differentiation amplification epidermal growth-factor ovarian cancer cell transformation assay 4-OHE2 diphospho-glucuronosyltransferase 1a1 genotype ugt1a1 promoter dna-binding domain dna-repair embryonic stem-cells cells syrian-hamsters gene control chemical carcinogens hamster tissues mutations tamoxifen saccharomyces-cerevisiae Promoter Regions (Genetics) genes 4-OH-E-2 UDP-glucuronosyltransferase 1A1 surface epithelium v79 cells surface epithelial-cells allelic loss ICI-182-780 induction line distinct regions Epidemiology tumors breast-cancer deprivation human cytogenetics growth antisense c-myc malignant transformation elements oligonucleotide disposition Breast cancer vitellogenin phenol sulfotransferases subunit factor receptor marker resistin levels functional genomics pyrosequencing CGH catechol estrogens sult1a1 enhancer of zeste homolog 2 Biochemistry & Molecular Biology prostate-specific serum adiponectin cancer quantitative-analysis polymerase chain reaction outcomes dna-damage human progesterone-receptor enhancer fetal incessant ovulation resection proliferative activity DNA family androgen deprivation Insertional Mutagenesis metabolic randomized-trials tumor suppressor radiotherapy follow-up c-myc disease human epidermal growth factor receptor 2 protein Biomarkers polarity gene polymorphism progesterone messenger-rna human bilirubin ovarian-cancer histone methyltransferase ezh2 alpha-interferon epidermal non-small cell lung cancer healthy postmenopausal women Oncology european case-control gland sulfotransferase 1A1 estrogen and progesterone receptors oncogene Obesity Gene Expression Regulation risk-factors promoter region SULTIAI positivity external-beam radiation smoking UGTIAI coatings stage radiation therapy beta receptor coactivator aib1 growth factor receptor sulfation carcinogenesis estrogen plus progestin cloned cdna prostate cancer polymorphism neoplastic transformation factor-alpha syndrome lines fat leucine zipper inhibitor cancer-cells genotoxicity adipose-tissue udp-glucuronosyltransferase Site-Directed Mutagenesis epithelial-cells carcinomas
Last updated on Wednesday, February 05, 2020